These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Outbreak of vanB vancomycin-resistant Enterococcus faecium colonization in a neonatal service. Lister DM; Kotsanas D; Ballard SA; Howden BP; Carse E; Tan K; Scott C; Gillespie EE; Mahony AA; Doherty R; Korman TM; Johnson PD; Stuart RL Am J Infect Control; 2015 Oct; 43(10):1061-5. PubMed ID: 26190380 [TBL] [Abstract][Full Text] [Related]
24. Linezolid- and Vancomycin-resistant Enterococcus faecium in Solid Organ Transplant Recipients: Infection Control and Antimicrobial Stewardship Using Whole Genome Sequencing. Abbo L; Shukla BS; Giles A; Aragon L; Jimenez A; Camargo JF; Simkins J; Sposato K; Tran TT; Diaz L; Reyes J; Rios R; Carvajal LP; Cardozo J; Ruiz M; Rosello G; Cardona AP; Martinez O; Guerra G; Beduschi T; Vianna R; Arias CA Clin Infect Dis; 2019 Jul; 69(2):259-265. PubMed ID: 30339217 [TBL] [Abstract][Full Text] [Related]
25. High rates of colonisation by ampicillin-resistant enterococci in residents of long-term care facilities in Porto, Portugal. Freitas AR; Novais C; Duarte B; Pereira AP; Coque TM; Peixe L Int J Antimicrob Agents; 2018 Mar; 51(3):503-507. PubMed ID: 29175606 [TBL] [Abstract][Full Text] [Related]
26. Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates. Klupp EM; Both A; Belmar Campos C; Büttner H; König C; Christopeit M; Christner M; Aepfelbacher M; Rohde H Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1957-1961. PubMed ID: 27525679 [TBL] [Abstract][Full Text] [Related]
27. First infection with VanD-type glycopeptide-resistant Enterococcus faecium in Europe. Lavigne JP; Marchandin H; Bouziges N; Sotto A J Clin Microbiol; 2005 Jul; 43(7):3512-5. PubMed ID: 16000493 [TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China. Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304 [TBL] [Abstract][Full Text] [Related]
29. Molecular epidemiology of glycopeptide-resistant Enterococcus faecium on a renal unit. Chadwick PR; Fox A; Woodford N Epidemiol Infect; 1997 Oct; 119(2):159-66. PubMed ID: 9363014 [TBL] [Abstract][Full Text] [Related]
30. Incidence, management and outcomes of the first cfr-mediated linezolid-resistant Staphylococcus epidermidis outbreak in a tertiary referral centre in the Republic of Ireland. O'Connor C; Powell J; Finnegan C; O'Gorman A; Barrett S; Hopkins KL; Pichon B; Hill R; Power L; Woodford N; Coffey JC; Kearns A; O'Connell NH; Dunne CP J Hosp Infect; 2015 Aug; 90(4):316-21. PubMed ID: 25648941 [TBL] [Abstract][Full Text] [Related]
31. Characterization and rapid control of a vancomycin-resistant Enterococcus faecium (VREF) outbreak in a renal transplant unit in Spain: The environment matters. Herrera S; Sorlí L; Pérez-Sáez MJ; Ruiz-Garbajosa P; Barrios C; Plasencia V; Montero M; Terradas R; Crespo M; Castells X; Cantón R; Pascual J; Horcajada JP Enferm Infecc Microbiol Clin; 2017 Jan; 35(1):5-11. PubMed ID: 27156245 [TBL] [Abstract][Full Text] [Related]
32. Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program. Deshpande LM; Ashcraft DS; Kahn HP; Pankey G; Jones RN; Farrell DJ; Mendes RE Antimicrob Agents Chemother; 2015 Oct; 59(10):6256-61. PubMed ID: 26248384 [TBL] [Abstract][Full Text] [Related]
33. The emerging problem of linezolid-resistant enterococci. Bi R; Qin T; Fan W; Ma P; Gu B J Glob Antimicrob Resist; 2018 Jun; 13():11-19. PubMed ID: 29101082 [TBL] [Abstract][Full Text] [Related]
35. 2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci - from disaster to ongoing control. Pearman JW J Hosp Infect; 2006 May; 63(1):14-26. PubMed ID: 16563562 [TBL] [Abstract][Full Text] [Related]
36. Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital. Werner G; Klare I; Spencker FB; Witte W J Antimicrob Chemother; 2003 Jul; 52(1):113-5. PubMed ID: 12805253 [TBL] [Abstract][Full Text] [Related]
37. Molecular analysis and distribution of multidrug-resistant Enterococcus faecium isolates belonging to clonal complex 17 in a tertiary care center in Mexico City. Ochoa SA; Escalona G; Cruz-Córdova A; Dávila LB; Saldaña Z; Cázares-Domímguez V; Eslava CA; López-Martínez B; Hernández-Castro R; Aquino-Jarquin G; Xicohtencatl-Cortes J BMC Microbiol; 2013 Dec; 13():291. PubMed ID: 24330424 [TBL] [Abstract][Full Text] [Related]
39. The emergence of glycopeptide-resistant Enterococcus faecium in a university hospital in southwestern Greece. Kolonitsiou F; Mani V; Parikou H; Trakala M; Dimitracopoulos G; Spiliopoulou I Chemotherapy; 2004 Nov; 50(5):245-9. PubMed ID: 15528890 [TBL] [Abstract][Full Text] [Related]
40. The use of high-throughput sequencing to investigate an outbreak of glycopeptide-resistant Enterococcus faecium with a novel quinupristin-dalfopristin resistance mechanism. Shaw TD; Fairley DJ; Schneiders T; Pathiraja M; Hill RLR; Werner G; Elborn JS; McMullan R Eur J Clin Microbiol Infect Dis; 2018 May; 37(5):959-967. PubMed ID: 29478197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]